Skip to main content

Table 3 Multi-drug resistance pattern of GBS isolated from pregnant women recruited from two health institutions (n = 43)

From: Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples

Pattern

Drugs resistance pattern (Antibiogram)

No. of drug to which strains were resistant

No. of MDR strains (%)

I

AMP:PEN:CEFA:VAN:TET

5

3/29 (10.3%)

II

AMP:PEN:CEFA:CLN:TET

5

2/29 (6.9%)

III

AMP:PEN:CEFA:CHL:TET

5

1/29 (3.4%)

IV

AMP:PEN:CLN:CRO:TET

5

1/29 (3.4%)

V

AMP:CEFA:CLN:CRO:TET

5

1/29 (3.4%)

VI

PEN:CEFA:CLN:CRO:TET

5

1/29 (3.4%)

VII

CEFA:ERY:CLN:CHL:TET

5

1/29 (3.4%)

VIII

AMP:PEN:CEFA:ERY:CRO:TET

6

1/29 (3.4%)

IX

AMP:PEN:CEFA:CLN:CRO:TET

6

1/29 (3.4%)

X

PEN:CEFA:CLN:CHL:CRO:TET

6

1/29 (3.4%)

XI

PEN:ERY:CLN:CHL:CRO:TET

6

1/29 (3.4%)

XII

CEFA:ERY:CLN:CHL:CRO:TET

6

1/29 (3.4%)

XIII

AMP:PEN:CEFA:VAN:ERY:CLN:TET

7

3/29 (10.3%)

XIV

AMP:PEN:CEFA:VAN:CLN:CRO:TET

7

1/29 (3.4%)

XV

AMP:PEN:CEFA:ERY:CLN:CRO:TET

7

1/29 (3.4%)

XVI

AMP:PEN:CEFA:VAN:CHL:CRO:TET

7

1/29 (3.4%)

XVII

AMP:PEN:CEFA:CLN:CHL:CRO:TET

7

1/29 (3.4%)

XVIII

AMP:PEN:CEFA:VAN:CLN:CHL:CRO:TET

8

3/29 (10.3%)

XXIV

AMP:PEN:CEFA:ERY:CLN:CHL:CRO:TET

8

2/29 (6.9%)

XXX

AMP:PEN:CEFA:VAN:ERY:CLN:CHL:TET

8

1/29 (3.4%)

XXXI

AMP:PEN:CEFA:VAN:ERY:CLN:CHL:CRO:TET

9

1/29 (3.4%)

  1. AMP Ampicillin, PEN Penicillin G, CEFA Cefazolin, VAN Vancomycin, ERY, Erythromycin, CLN Clindamycin, CHL Chloramphenicol, CRO Ceftriaxone, TET Tetracycline (based on disk diffusion method)